Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92161


Purpose:

This study will assess whether olanzapine and/or risperidone affect the way the human body uses sugar in the blood.


Criteria:

Inclusion Criteria: - 18-65 years old - Diagnosed with Schizophrenia or Schizoaffective disorder - Ability to visit the doctor's office for scheduled visits Exclusion Criteria: - Women who are pregnant or breastfeeding - Have a body mass index (BMI) greater than 40 - Have diabetes, heart disease or any other unstable illness - Have known positive human immunodeficiency virus (HIV) - Are currently taking olanzapine, risperidone, clozapine, glucocorticoids, injectable antipsychotics


NCT ID:

NCT00190749


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

San Diego, California 92161
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.